Balyasny Asset Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.67M | Buy |
604,561
+11,586
| +2% | +$185K | 0.01% | 698 |
|
|
2025
Q1 | $9.02M | Buy |
+592,975
| New | +$9.02M | 0.01% | 683 |
|
|
2024
Q2 | – | Sell |
-20,100
| Closed | -$460K | – | 2421 |
|
|
2024
Q1 | $460K | Sell |
20,100
-324,027
| -94% | -$7.42M | ﹤0.01% | 1508 |
|
|
2023
Q4 | $9.01M | Buy |
344,127
+197,567
| +135% | +$5.17M | 0.02% | 656 |
|
|
2023
Q3 | $4.12M | Buy |
146,560
+56,083
| +62% | +$1.58M | 0.01% | 830 |
|
|
2023
Q2 | $2.75M | Buy |
+90,477
| New | +$2.75M | 0.01% | 935 |
|